Potential Payment of Contingent Consideration Related to the CUCMS Acquisition
First written in FY2024-Q2. 4 of 6 entries say "Restated". Latest entry: FY2026.
No other company in this theme has enough history to compare yet.
- FY2026MitigatedAnnual report
「The contingent consideration arising from the business combination involving CUCMS depends on progress toward satisfying the Conditions Subsequent agreed with the sellers of the shares when CUCMS was acquired in October 2019. These conditions include obtaining a license for the pharmacy business and completing procedures for acquiring land from the sellers. Accordingly, we may be required to pay up to VND37.3 billion.」
The maximum contingent consideration related to CUCMS has decreased from the previously stated VND87.0 billion to VND37.3 billion. - FY2026-H1RestatedAnnual report
「Accordingly, we may be required to pay up to VND87.0 billion.」
The possibility of paying up to VND87.0 billion in contingent consideration related to the CUCMS acquisition continues to be disclosed. - FY2025-H1RestatedAnnual report
「The contingent consideration arising from the business combination involving CUCMS depends on progress toward satisfying the Conditions Subsequent agreed with the sellers of the shares when CUCMS was acquired in October 2019. These conditions include obtaining a license for the pharmacy business and completing procedures for acquiring land from the sellers. Accordingly, we may be required to pay up to VND87.0 billion.」
The possibility of paying up to VND87.0 billion in contingent consideration related to the CUCMS acquisition continues to be disclosed. - FY2024RestatedAnnual report
「The contingent consideration arising from the business combination involving CUCMS depends on progress toward satisfying the Conditions Subsequent agreed with the sellers of the shares when CUCMS was acquired in October 2019. These conditions include obtaining a license for the pharmacy business and completing procedures for acquiring land from the sellers. Accordingly, we may be required to pay up to VND87.0 billion.」
The possibility of paying up to VND87.0 billion in contingent consideration related to the CUCMS acquisition continues to be disclosed. - FY2024-Q3RestatedAnnual report
「The contingent consideration arising from the business combination involving CUCMS depends on progress toward satisfying the Conditions Subsequent agreed with the sellers of the shares when CUCMS was acquired in October 2019. These conditions include obtaining a license for the pharmacy business and completing procedures for acquiring land from the sellers. Accordingly, we may be required to pay up to VND87.0 billion.」
The possibility of paying up to VND87.0 billion in contingent consideration related to the CUCMS acquisition continues to be disclosed. - FY2024-Q2First statedAnnual report
「The contingent consideration arising from the business combination involving CUCMS depends on progress toward satisfying the Conditions Subsequent agreed with the sellers of the shares when CUCMS was acquired in October 2019. These conditions include obtaining a license for the pharmacy business and completing procedures for acquiring land from the sellers. Accordingly, we may be required to pay up to VND87.0 billion.」
The company discloses the possibility of paying up to VND87.0 billion in contingent consideration depending on progress toward obtaining the pharmacy license and completing the land transfer.